qbkpn
Biologicalexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2014 (NCT02256852)
Timeline
Indications
Mechanism of action
- UnclearImmunity, active
Unclear immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- qbkpn
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05421325 | Phase 2 | Sep 30, 2022 | Qu Biologics, University of British Columbia |
| NCT02897999 | Phase 1 | Sep 1, 2016 | Qu Biologics |
| NCT02256852 | Phase 2 | Dec 1, 2014 | British Columbia Cancer Agency, Qu Biologics |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Qu Biologics | For profit | 3 | 3 | 2 | 2014 |
| British Columbia Cancer Agency | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of British Columbia | Academic/Hospital | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1